Literature DB >> 27488627

Presynaptic Deficits at Neuromuscular Junctions: A Specific Cause and Potential Target of Axonal Neuropathy in Type 2 Charcot-Marie-Tooth Disease.

Gursimran Chandhok1, Ming Shiuan Soh2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27488627      PMCID： PMC6601953          DOI： 10.1523/JNEUROSCI.1515-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  22 in total

1.  Distinct roles for secreted semaphorin signaling in spinal motor axon guidance.

Authors:  Andrea B Huber; Artur Kania; Tracy S Tran; Chenghua Gu; Natalia De Marco Garcia; Ivo Lieberam; Dontais Johnson; Thomas M Jessell; David D Ginty; Alex L Kolodkin
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

2.  Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.

Authors:  Qian-Sheng Yu; Harold W Holloway; Weiming Luo; Debomoy K Lahiri; Arnold Brossi; Nigel H Greig
Journal:  Bioorg Med Chem       Date:  2010-05-12       Impact factor: 3.641

3.  Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease.

Authors:  Eng-Tat Ang; Ralf Schäfer; Richard Baltensperger; Anton Wernig; Marco Celio; Sara Sancho Oliver
Journal:  J Neuropathol Exp Neurol       Date:  2010-03       Impact factor: 3.685

4.  An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.

Authors:  Kevin L Seburn; Leslie A Nangle; Gregory A Cox; Paul Schimmel; Robert W Burgess
Journal:  Neuron       Date:  2006-09-21       Impact factor: 17.173

5.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

Authors:  B Oosthuyse; L Moons; E Storkebaum; H Beck; D Nuyens; K Brusselmans; J Van Dorpe; P Hellings; M Gorselink; S Heymans; G Theilmeier; M Dewerchin; V Laudenbach; P Vermylen; H Raat; T Acker; V Vleminckx; L Van Den Bosch; N Cashman; H Fujisawa; M R Drost; R Sciot; F Bruyninckx; D J Hicklin; C Ince; P Gressens; F Lupu; K H Plate; W Robberecht; J M Herbert; D Collen; P Carmeliet
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

6.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

7.  An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.

Authors:  Francesca Achilli; Virginie Bros-Facer; Hazel P Williams; Gareth T Banks; Mona AlQatari; Ruth Chia; Valter Tucci; Michael Groves; Carole D Nickols; Kevin L Seburn; Rachel Kendall; Muhammed Z Cader; Kevin Talbot; Jan van Minnen; Robert W Burgess; Sebastian Brandner; Joanne E Martin; Martin Koltzenburg; Linda Greensmith; Patrick M Nolan; Elizabeth M C Fisher
Journal:  Dis Model Mech       Date:  2009-05-26       Impact factor: 5.758

8.  Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.

Authors:  Sabine Lindquist; Martin Stangel
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-30       Impact factor: 2.570

9.  New acetylcholinesterase inhibitors for Alzheimer's disease.

Authors:  Mona Mehta; Abdu Adem; Marwan Sabbagh
Journal:  Int J Alzheimers Dis       Date:  2011-12-15

10.  Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.

Authors:  William W Motley; Kevin L Seburn; Mir Hussain Nawaz; Kathy E Miers; Jun Cheng; Anthony Antonellis; Eric D Green; Kevin Talbot; Xiang-Lei Yang; Kenneth H Fischbeck; Robert W Burgess
Journal:  PLoS Genet       Date:  2011-12-01       Impact factor: 5.917
View more
  2 in total

1.  The sympathetic nervous system regulates skeletal muscle motor innervation and acetylcholine receptor stability.

Authors:  Anna C Z Rodrigues; Maria L Messi; Zhong-Min Wang; Martin C Abba; Andrea Pereyra; Alexander Birbrair; Tan Zhang; Meaghan O'Meara; Ping Kwan; Elsa I S Lopez; Monte S Willis; Akiva Mintz; D Clark Files; Cristina Furdui; Ronald W Oppenheim; Osvaldo Delbono
Journal:  Acta Physiol (Oxf)       Date:  2018-10-22       Impact factor: 6.311

2.  Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans.

Authors:  Ming S Soh; Xinran Cheng; Tarika Vijayaraghavan; Arwen Vernon; Jie Liu; Brent Neumann
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.